These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24787917)

  • 21. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic mild stress accelerates the onset and progression of the Alzheimer's disease phenotype in Tg2576 mice.
    Cuadrado-Tejedor M; Ricobaraza A; Frechilla D; Franco R; Pérez-Mediavilla A; Garcia-Osta A
    J Alzheimers Dis; 2012; 28(3):567-78. PubMed ID: 22045482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease.
    Schmand B; Huizenga HM; van Gool WA
    Psychol Med; 2010 Jan; 40(1):135-45. PubMed ID: 19863841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased total TAU but not amyloid-beta(42) in cerebrospinal fluid correlates with short-term memory impairment in Alzheimer's disease.
    Lin YT; Cheng JT; Yao YC; Juo ; Lo YK; Lin CH; Ger LP; Lu PJ
    J Alzheimers Dis; 2009; 18(4):907-18. PubMed ID: 19749420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease-like pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondria-targeted antioxidant SkQ1.
    Stefanova NA; Muraleva NA; Skulachev VP; Kolosova NG
    J Alzheimers Dis; 2014; 38(3):681-94. PubMed ID: 24047616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of the benzodiazepine midazolam increases tau phosphorylation in the mouse brain.
    Whittington RA; Virág L; Gratuze M; Lewkowitz-Shpuntoff H; Cheheltanan M; Petry F; Poitras I; Morin F; Planel E
    Neurobiol Aging; 2019 Mar; 75():11-24. PubMed ID: 30508732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR; Zhou WX; Zhang YX
    Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid and tau neuropathology differentially affect prefrontal synaptic plasticity and cognitive performance in mouse models of Alzheimer's disease.
    Lo AC; Iscru E; Blum D; Tesseur I; Callaerts-Vegh Z; Buée L; De Strooper B; Balschun D; D'Hooge R
    J Alzheimers Dis; 2013; 37(1):109-25. PubMed ID: 23788007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
    Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
    Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Does Alzheimer's disease exist in all primates? Alzheimer pathology in non-human primates and its pathophysiological implications (II)].
    Toledano A; Álvarez MI; López-Rodríguez AB; Toledano-Díaz A; Fernández-Verdecia CI
    Neurologia; 2014; 29(1):42-55. PubMed ID: 21871692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetyl-L-carnitine attenuates okadaic acid induced tau hyperphosphorylation and spatial memory impairment in rats.
    Yin YY; Liu H; Cong XB; Liu Z; Wang Q; Wang JZ; Zhu LQ
    J Alzheimers Dis; 2010; 19(2):735-46. PubMed ID: 20110616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
    García-Mesa Y; López-Ramos JC; Giménez-Llort L; Revilla S; Guerra R; Gruart A; Laferla FM; Cristòfol R; Delgado-García JM; Sanfeliu C
    J Alzheimers Dis; 2011; 24(3):421-54. PubMed ID: 21297257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia.
    Tong Z; Zhang J; Luo W; Wang W; Li F; Li H; Luo H; Lu J; Zhou J; Wan Y; He R
    Neurobiol Aging; 2011 Jan; 32(1):31-41. PubMed ID: 19879019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study.
    Sluimer JD; Bouwman FH; Vrenken H; Blankenstein MA; Barkhof F; van der Flier WM; Scheltens P
    Neurobiol Aging; 2010 May; 31(5):758-64. PubMed ID: 18692273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
    Buerger K; Ewers M; Pirttilä T; Zinkowski R; Alafuzoff I; Teipel SJ; DeBernardis J; Kerkman D; McCulloch C; Soininen H; Hampel H
    Brain; 2006 Nov; 129(Pt 11):3035-41. PubMed ID: 17012293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tau transgenic mice as models for cerebrospinal fluid tau biomarkers.
    Barten DM; Cadelina GW; Hoque N; DeCarr LB; Guss VL; Yang L; Sankaranarayanan S; Wes PD; Flynn ME; Meredith JE; Ahlijanian MK; Albright CF
    J Alzheimers Dis; 2011; 24 Suppl 2():127-41. PubMed ID: 21422517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.